Mednova, I.A.; Mikhalitskaya, E.V.; Vyalova, N.M.; Paderina, D.Z.; Petkun, D.A.; Tiguntsev, V.V.; Kornetova, E.G.; Bokhan, N.A.; Ivanova, S.A.
The Role of GST Gene Polymorphic Variants in Antipsychotic-Induced Metabolic Disorders in Schizophrenia: A Pilot Study. Pharmaceuticals 2025, 18, 941.
https://doi.org/10.3390/ph18070941
AMA Style
Mednova IA, Mikhalitskaya EV, Vyalova NM, Paderina DZ, Petkun DA, Tiguntsev VV, Kornetova EG, Bokhan NA, Ivanova SA.
The Role of GST Gene Polymorphic Variants in Antipsychotic-Induced Metabolic Disorders in Schizophrenia: A Pilot Study. Pharmaceuticals. 2025; 18(7):941.
https://doi.org/10.3390/ph18070941
Chicago/Turabian Style
Mednova, Irina A., Ekaterina V. Mikhalitskaya, Natalia M. Vyalova, Diana Z. Paderina, Dmitry A. Petkun, Vladimir V. Tiguntsev, Elena G. Kornetova, Nikolay A. Bokhan, and Svetlana A. Ivanova.
2025. "The Role of GST Gene Polymorphic Variants in Antipsychotic-Induced Metabolic Disorders in Schizophrenia: A Pilot Study" Pharmaceuticals 18, no. 7: 941.
https://doi.org/10.3390/ph18070941
APA Style
Mednova, I. A., Mikhalitskaya, E. V., Vyalova, N. M., Paderina, D. Z., Petkun, D. A., Tiguntsev, V. V., Kornetova, E. G., Bokhan, N. A., & Ivanova, S. A.
(2025). The Role of GST Gene Polymorphic Variants in Antipsychotic-Induced Metabolic Disorders in Schizophrenia: A Pilot Study. Pharmaceuticals, 18(7), 941.
https://doi.org/10.3390/ph18070941
